GAAP SG&A expenditures were $227.5 million this year 2010, in comparison to $172.8 million for the prior year. Balance Sheet: By December 31, 2010, the business acquired $361.6 million in cash, cash equivalents and marketable securities in comparison to $ December 31 2 million, 2009. In January and February 2011, the Company utilized $114 million of available cash for the Taligen and Orphatec acquisitions described below. Q4 Research and Advancement Progress: Through the fourth one fourth of 2010, Alexion made significant progress on advancing the development of eculizumab as a treatment for patients experiencing additional rare and severe complement-mediated disorders beyond PNH, with a concentrate on its two lead nephrology applications in transplant and aHUS.Finally, those people who are more concerned about government tyranny correctly point out that the federal government has recently asserted executive purchase control over all food, farms and livestock. Just the wildly ignorant don’t store extra meals for emergency preparedness. Actually the federal government’s program urges people to ‘have a plan’ and make a disaster supplies package which contains, ‘at least a three-day way to obtain nonperishable food’ – – just enough to maintain you alive until FEMA arrives and screws everything up. The problem is that even well-meaning Americans who want to prepare for the worst are often going about it all wrong.